Innoviva INVA Q1 2026 Disappoints EPS 005 Below 040 Views Warren Buffetts Tiny Purchase Revealed Berkshire Filing Hints at New Investment Chicago REFI Stock Today Drops 102 Key Support at 1065 20260515 Inflation Pressures Broaden Beyond Energy as Consumer Prices Reaccelerate Across Key Sectors Wall Street Gains Ground as Chip Stocks Surge Ahead of Nvidia Earnings Arcellx ACLX Posts Record Q4 2025 EPS 101 Blows Past Estimates electroCore ECOR Q1 2026 Earnings 037 EPS Surges Past 062 Estimates Singapore Strengthens AI Ecosystem with Strategic Google and OpenAI Partnerships Chinas Worst Mining Disaster in Over a Decade Claims 82 Lives at Liushenyu Mine Implications for Coal Sector Safety Should This 62YearOld Claim Social Security Now or Wait for Survivor Benefits Target Signals Positive Developments for Shareholders White House Announces Agricultural and Rare Earths Agreements Following TrumpXi Summit Spelling Bee Coach Scott Remer Carves Lucrative Niche 180Hour and PerformanceBased Fees Robotic Garment Manufacturing Could Automation Reshape Global Textile Supply Chains MELI Q1 2026 Earnings EPS Miss Despite Strong Operational Momentum Scienture Holdings Inc SCNX Q1 2026 Earnings Narrowerthanexpected loss drives positive surprise PZG Q1 2026 Earnings EPS Misses Estimates Sharply Amid Exploration Focus Burford Capital Q1 2026 Earnings Massive EPS Miss with 5273 Surprise Drains Investor Confidence AFCG Q1 2026 Earnings Strong EPS Surprise of 328 Driven by Portfolio Performance Heritage Global HGBL Stock Slides 148 Support at 114 20260515 Salesforce CRM Crushes Q1 2026 Estimates EPS 381 Tops Views Farmland Partners FPI Climbs 192 Resistance at 1088 in Focus 20260518 Diginex DGNX Slips 1625 Testing 095 Support 20260514 Workhorse Group WKHS Q1 2026 Results Miss Estimates EPS 199 vs 150 BlackRocks CORO ETF Outperforms Benchmark by 6 Points CreativeOne Wealth Discloses 55M Stake Standard Chartered to Cut Over 15 of Corporate Functions Roles by 2030 as Part of Profitability Drive LXEO Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances